Use of aminocaproic acid (ACA) in extra-amniotic MTP in patients on anti-coagulant therapy.

P. P. Kale*, M. A. Shah, A. V. Pathare

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A case of rheumatic heart disease (RHD) with prosthetic mitral valve endocarditis receiving anticoagulation with heparin, underwent medical termination of pregnancy in a second trimester. The following report entails the use of aminocaproic acid (ACA) in preventing excessive bleeding during and after the procedure, while the patient continued to receive anticoagulant therapy.

Original languageEnglish
Pages (from-to)199-200
Number of pages2
JournalJournal of Postgraduate Medicine
Volume38
Issue number4
Publication statusPublished - Oct 1992

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Use of aminocaproic acid (ACA) in extra-amniotic MTP in patients on anti-coagulant therapy.'. Together they form a unique fingerprint.

  • Cite this